nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—Epinephrine—TNF—atherosclerosis	0.00179	1	CrCbGaD
Dipivefrin—ADRA2C—Signaling Pathways—SOCS3—atherosclerosis	0.000151	0.000152	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—APOB—atherosclerosis	0.000151	0.000151	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000151	0.000151	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—CXCL8—atherosclerosis	0.00015	0.00015	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—APOB—atherosclerosis	0.000149	0.00015	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—INS—atherosclerosis	0.000149	0.000149	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—EDN1—atherosclerosis	0.000149	0.000149	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000148	0.000148	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCL5—atherosclerosis	0.000148	0.000148	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—EDN1—atherosclerosis	0.000147	0.000147	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—F2—atherosclerosis	0.000147	0.000147	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—VEGFA—atherosclerosis	0.000146	0.000146	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MMP3—atherosclerosis	0.000146	0.000146	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCL5—atherosclerosis	0.000146	0.000146	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IGF2—atherosclerosis	0.000145	0.000146	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—MTHFR—atherosclerosis	0.000145	0.000145	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—LPL—atherosclerosis	0.000144	0.000145	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	0.000144	0.000144	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	0.000143	0.000144	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—HMOX1—atherosclerosis	0.000143	0.000143	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—LPL—atherosclerosis	0.000142	0.000143	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PPARA—atherosclerosis	0.000142	0.000143	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APOB—atherosclerosis	0.000141	0.000141	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	0.000141	0.000141	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PIK3CG—atherosclerosis	0.00014	0.000141	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PRKCG—atherosclerosis	0.00014	0.000141	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	0.00014	0.00014	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—CXCL8—atherosclerosis	0.00014	0.00014	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PLG—atherosclerosis	0.00014	0.00014	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—EDN1—atherosclerosis	0.000139	0.000139	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	0.000139	0.000139	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—MAPK3—atherosclerosis	0.000138	0.000138	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—AGT—atherosclerosis	0.000138	0.000138	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCL5—atherosclerosis	0.000138	0.000138	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—APOB—atherosclerosis	0.000137	0.000137	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SPP1—atherosclerosis	0.000137	0.000137	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—ALB—atherosclerosis	0.000137	0.000137	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—CXCL8—atherosclerosis	0.000136	0.000136	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PPARG—atherosclerosis	0.000136	0.000136	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—APOE—atherosclerosis	0.000135	0.000135	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SPP1—atherosclerosis	0.000135	0.000135	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—LPL—atherosclerosis	0.000135	0.000135	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	0.000134	0.000135	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TGFB1—atherosclerosis	0.000134	0.000134	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	0.000134	0.000134	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CAV1—atherosclerosis	0.000134	0.000134	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—APOA1—atherosclerosis	0.000134	0.000134	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GSTM1—atherosclerosis	0.000133	0.000134	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	0.000133	0.000133	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—INS—atherosclerosis	0.000133	0.000133	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	0.000132	0.000132	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PRKCG—atherosclerosis	0.000131	0.000131	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—LPL—atherosclerosis	0.000131	0.000131	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—NOS3—atherosclerosis	0.000131	0.000131	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	0.000131	0.000131	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PLG—atherosclerosis	0.00013	0.00013	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GPX1—atherosclerosis	0.000128	0.000128	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	0.000128	0.000128	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SPP1—atherosclerosis	0.000128	0.000128	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	0.000127	0.000127	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—CXCL8—atherosclerosis	0.000127	0.000127	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	0.000126	0.000127	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	0.000125	0.000125	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CD36—atherosclerosis	0.000124	0.000125	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AGT—atherosclerosis	0.000123	0.000124	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APOB—atherosclerosis	0.000123	0.000124	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—AKT1—atherosclerosis	0.000123	0.000123	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	0.000123	0.000123	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000122	0.000123	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PIK3CG—atherosclerosis	0.000122	0.000122	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AGT—atherosclerosis	0.000122	0.000122	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—ALB—atherosclerosis	0.000122	0.000122	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	0.000121	0.000122	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—APOE—atherosclerosis	0.000121	0.000121	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—LEP—atherosclerosis	0.000121	0.000121	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	0.000121	0.000121	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	0.00012	0.00012	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	0.00012	0.00012	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PTGS2—atherosclerosis	0.000119	0.00012	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—LEP—atherosclerosis	0.000119	0.00012	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—APOE—atherosclerosis	0.000119	0.00012	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	0.000119	0.000119	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CAV1—atherosclerosis	0.000118	0.000119	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PDGFB—atherosclerosis	0.000118	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	0.000118	0.000118	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—APOA1—atherosclerosis	0.000118	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—MTHFR—atherosclerosis	0.000118	0.000118	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—LPL—atherosclerosis	0.000118	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PPARG—atherosclerosis	0.000118	0.000118	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—NOS3—atherosclerosis	0.000117	0.000117	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PPARA—atherosclerosis	0.000116	0.000116	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	0.000116	0.000116	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—INS—atherosclerosis	0.000115	0.000116	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AGT—atherosclerosis	0.000115	0.000116	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—AKT1—atherosclerosis	0.000115	0.000115	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APOB—atherosclerosis	0.000115	0.000115	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	0.000115	0.000115	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—F2—atherosclerosis	0.000114	0.000114	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ESR1—atherosclerosis	0.000114	0.000114	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000114	0.000114	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APOE—atherosclerosis	0.000113	0.000113	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—LEP—atherosclerosis	0.000113	0.000113	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	0.000113	0.000113	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—F2—atherosclerosis	0.000113	0.000113	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AGT—atherosclerosis	0.000112	0.000112	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	0.000112	0.000112	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CAV1—atherosclerosis	0.000112	0.000112	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APOA1—atherosclerosis	0.000112	0.000112	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	0.000112	0.000112	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	0.000111	0.000111	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—APOE—atherosclerosis	0.00011	0.00011	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—LPL—atherosclerosis	0.00011	0.00011	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	0.000109	0.000109	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CAV1—atherosclerosis	0.000109	0.000109	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—APOA1—atherosclerosis	0.000109	0.000109	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ESR1—atherosclerosis	0.000108	0.000108	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	0.000108	0.000108	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PTGS2—atherosclerosis	0.000107	0.000107	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—F2—atherosclerosis	0.000107	0.000107	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	0.000106	0.000107	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ALB—atherosclerosis	0.000106	0.000106	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	0.000105	0.000105	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	0.000104	0.000104	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—INS—atherosclerosis	0.000103	0.000104	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	0.000103	0.000103	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	0.000103	0.000103	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	0.000103	0.000103	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—INS—atherosclerosis	0.000102	0.000102	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	0.000102	0.000102	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	0.000102	0.000102	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—NOS3—atherosclerosis	0.000101	0.000101	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGT—atherosclerosis	0.000101	0.000101	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCL2—atherosclerosis	0.0001	0.000101	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	0.0001	0.0001	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PIK3CG—atherosclerosis	9.91e-05	9.93e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APOE—atherosclerosis	9.88e-05	9.9e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—LEP—atherosclerosis	9.88e-05	9.9e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IGF1—atherosclerosis	9.87e-05	9.89e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	9.79e-05	9.81e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	9.77e-05	9.79e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	9.77e-05	9.78e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—INS—atherosclerosis	9.65e-05	9.67e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	9.6e-05	9.61e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PPARG—atherosclerosis	9.56e-05	9.58e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	9.5e-05	9.52e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	9.49e-05	9.51e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	9.43e-05	9.45e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—INS—atherosclerosis	9.38e-05	9.4e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	9.37e-05	9.39e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGT—atherosclerosis	9.37e-05	9.39e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	9.34e-05	9.36e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—AKT1—atherosclerosis	9.32e-05	9.34e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—F2—atherosclerosis	9.32e-05	9.33e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PTGS2—atherosclerosis	9.26e-05	9.28e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—LEP—atherosclerosis	9.18e-05	9.2e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APOE—atherosclerosis	9.18e-05	9.2e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	9.09e-05	9.11e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	9.07e-05	9.09e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	9.06e-05	9.08e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NOS3—atherosclerosis	8.95e-05	8.96e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	8.92e-05	8.93e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	8.87e-05	8.88e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	8.76e-05	8.78e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—F2—atherosclerosis	8.66e-05	8.67e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ALB—atherosclerosis	8.6e-05	8.61e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	8.54e-05	8.55e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	8.47e-05	8.48e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—INS—atherosclerosis	8.44e-05	8.46e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	8.3e-05	8.32e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	8.28e-05	8.3e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—NOS3—atherosclerosis	8.22e-05	8.24e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	8.16e-05	8.18e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	8.04e-05	8.05e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	7.94e-05	7.95e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	7.93e-05	7.95e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—INS—atherosclerosis	7.84e-05	7.86e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	7.77e-05	7.78e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	7.75e-05	7.77e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	7.72e-05	7.73e-05	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	7.67e-05	7.68e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	7.65e-05	7.66e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	7.59e-05	7.6e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—IL6—atherosclerosis	7.55e-05	7.56e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PTGS2—atherosclerosis	7.52e-05	7.54e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	7.51e-05	7.52e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	7.4e-05	7.41e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	7.27e-05	7.29e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	7.26e-05	7.27e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	7.2e-05	7.22e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	7.19e-05	7.21e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MMP9—atherosclerosis	7.18e-05	7.19e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	7.14e-05	7.15e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	7.1e-05	7.12e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	7.07e-05	7.09e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	7.05e-05	7.07e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	6.98e-05	6.99e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	6.96e-05	6.98e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	6.88e-05	6.89e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	6.79e-05	6.81e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	6.72e-05	6.73e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	6.61e-05	6.62e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	6.59e-05	6.6e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	6.57e-05	6.58e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	6.53e-05	6.54e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	6.47e-05	6.48e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	6.45e-05	6.46e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—STAT3—atherosclerosis	6.38e-05	6.39e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	6.34e-05	6.35e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	6.24e-05	6.25e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	6.18e-05	6.19e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	6.1e-05	6.11e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	6.1e-05	6.11e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	6.1e-05	6.11e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	6.04e-05	6.05e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—AKT1—atherosclerosis	6.01e-05	6.02e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	5.99e-05	6e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	5.94e-05	5.95e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	5.92e-05	5.93e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	5.89e-05	5.9e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	5.88e-05	5.89e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	5.8e-05	5.81e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	5.78e-05	5.79e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	5.77e-05	5.78e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	5.76e-05	5.77e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	5.6e-05	5.61e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	5.52e-05	5.53e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	5.46e-05	5.47e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	5.37e-05	5.38e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—AKT1—atherosclerosis	5.36e-05	5.37e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	5.35e-05	5.36e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	5.33e-05	5.34e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	5.28e-05	5.29e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	5.04e-05	5.05e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	4.95e-05	4.96e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	4.91e-05	4.91e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	4.89e-05	4.9e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	4.69e-05	4.7e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—AKT1—atherosclerosis	4.65e-05	4.66e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	4.55e-05	4.56e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL6—atherosclerosis	4.52e-05	4.52e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL6—atherosclerosis	4.46e-05	4.47e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL6—atherosclerosis	4.22e-05	4.23e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	4.17e-05	4.17e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AKT1—atherosclerosis	4.11e-05	4.12e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	3.89e-05	3.9e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AKT1—atherosclerosis	3.78e-05	3.79e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL6—atherosclerosis	3.69e-05	3.69e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL6—atherosclerosis	3.43e-05	3.43e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	3.4e-05	3.41e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	3.16e-05	3.17e-05	CbGpPWpGaD
